BBP

Fund Description
Virtus LifeSci Biotech Products ETF (the "Products Fund") is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Products Index. Products stage companies are typically more established companies with much clinical trial failure risk behind them.
Fund Profile
Fund Name Virtus LifeSci Biotech Products ETF
Fund Exchange Ticker BBP
Fund Sponsor Bioshares
Fund ISIN US26923G2021
Net Expense Ratio 0.79 %
Fund Inception Date 17 December 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name LifeSci Biotechnology Products Index
Index Provider LifeSci Index Partners
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 22 January 2019
Asset Under Management 27.90 Million (USD)
1 Month Total Return 15.05 %
Year To Date Return 14.00 %
1 Year Total Return -3.65 %
3 Year Annualized Total Return 16.56 %
NAV 39.8606
Share Outstanding 700,004
Top 10 Holdings (22 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
BNY MELLON CASH RESERVE USD MMKT 0.0253
INSMED INC INSM EQUI 0.0169
EPIZYME INC EPZM EQUI 0.0166
MIRATI THERAPEUTICS INC MRTX EQUI 0.0162
AGENUS INC AGEN EQUI 0.0152
SAGE THERAPEUTICS INC SAGE EQUI 0.0141
FIBROGEN INC FGEN EQUI 0.0138
NIGHTSTAR THERAPEUTICS PLC NITE EQUI 0.0138
REATA PHARMACEUTICALS INC-A RETA EQUI 0.0131
BLUEBIRD BIO INC BLUE EQUI 0.013